FDA Inspection 1146227 — Baxalta US Inc.
The FDA completed an inspection of Baxalta US Inc. on July 1, 2021 in Social Circle, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 1, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Social Circle, GA (United States)